Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Critical decisions before courts and legislators in 2023 shape future of 340B Drug Pricing Program that provides discounts on outpatient drugs for covered entities. Financial impact on health care industry pharmaceutical manufacturers 340B hospitals and federal grantees.
Johnson, Spanberger Introduce Bipartisan Bill to Protect 340B Program, Prevent Higher Drug Prices Washington, D.C. – Today, U.S. Representatives Dusty Johnson (R-S.D.) and Abigail Spanberger (D-VA-07) introduced a bipartisan bill that would prohibit health insurers and PBMs from discriminating against 340B Drug Pricing Program providers or their contract pharmacies on the basis of their status…
The arbitrage of drug discounts has tilted the 340B program away from serving the low-income populations that the program was originally intended to help.
Critical decisions are pending before courts and legislators in 2023 that promise to shape the future of the 340B Drug Pricing Program (340B Program), which provides discounts on...
In the case of a 340B Covered Entity and the prime vendor program, the plantiff has filed an opposition to the defendant’s motion to dismiss the case. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates